Assessment of gas exchange in lung disease: balancing accuracy against feasibility by Wagner, Peter D
Page 1 of 2
(page number not for citation purposes)
Available online http://ccforum.com/content/11/6/182
Abstract
While the principles underlying alveolar gas exchange have been
well-known for over 50 years, we still struggle to assess gas
exchange in hypoxemic patients. Unfortunately, simple measure-
ments lack discrimination while complex measurements are
infeasible in clinical care. The paper by Karbing et al. in this issue
seeks a middle ground based on the arterial PO2 (PaO2)/inspired
O2 fraction (FIO2) ratio measured at different FIO2s with the out-
comes fed into proprietary software to account for both shunting
and ventilation/perfusion inequality. Whether this is the optimal
compromise between measurement difficulty and information
available will have to be answered by those willing to test the
approach in their own patients.
It never ceases to amaze me that the primary function of the
lungs — gas exchange — can be accurately described by one
simple mass conservation equation. Such cannot be said for
any other organ. However, while this was well established over
50 years ago [1,2], we continue to struggle for ways to quantify
abnormal gas exchange in patients with hypoxemia. The
problem boils down to the complexity of gas exchange in
diseased lungs, where hypoxemia can stem from, firstly,
insufficient overall ventilation; secondly, shunting of blood
through unventilated vascular channels; thirdly, non-uniform
distribution of ventilation, perfusion, or both throughout the 300
million or so alveoli; and fourthly, diffusion limitation of O2
exchange across the alveolar wall [3]. Added to these four well-
known causes of hypoxemia is the also well-known modulation
of arterial oxygenation by so-called extra-pulmonary factors: O2
consumption, ventilation, cardiac output, acid/base state, Hb
P50 and concentration, and body temperature [4]. Thus, when
any of these extra-pulmonary factors change, so too will arterial
oxygenation even if the lungs themselves remain unchanged.
As if that were not enough, as inspired O2 fraction (FIO2) is
altered, the arterial O2 saturation changes, but the response is
different depending on these various factors [5].
It should therefore come as no surprise that to fully assess
gas exchange in any given patient, one really needs to be
able to pin down each and every factor just mentioned. That
of course is impractical (although technically feasible).
That leaves us wondering what the compromise should be.
We want the most information at the least experimental cost.
We want methodology that will quantify a gas exchange
problem in a manner that allows reliable pulmonary patho-
physiological insights and also filters out the “noise” from
factors outside the lungs that, as mentioned above, affect gas
exchange. Unfortunately, full understanding requires complex
measurements — there is no short cut, and you get what you
pay for.
At the simplest extreme, arterial PO2 (PaO2) or saturation do
not do it, being sensitive to all the above factors: low
experimental cost but poor discrimination between lung
pathologies and between lung pathologies and the extra-
pulmonary modulating factors. At the most complex extreme,
the multiple inert gas elimination technique is currently the
best tool to fully understand the nature of gas exchange [6,7],
but the experimental cost is too high for routine clinical use.
The paper by Karbing et al. in this issue [8] tackles this
optimization problem by re-examining the PaO2/FIO2 ratio, an
index which has gained favor in recent years. They correctly
point out that this ratio is NOT independent of FIO2 despite its
intent. They explore the behavior of this ratio under two
common circumstances: two of the four causes of hypoxemia
noted above — shunting and ventilation/perfusion (V
￿
A/Q
￿
)
inequality. Applying this ratio to several sets of patients they
show that while in some the ratio behaves as if the lung has a
pure shunt, in others it behaves as if V
￿
A/Q
￿
inequality is the
problem. In others, both shunt and inequality are present. If
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PaO2/FIO2 is assessed at just one FIO2, one often cannot tell
shunt from inequality. Many combinations of shunt and
inequality can produce similar ratios at a given FIO2.
Their conclusion — to use PaO2/ FIO2 as input to a model that
includes both shunt and inequality to provide a more reliable
view of the lungs than will be given by the ratio itself or by a
model that allows only for shunt — should be self-evident. To
do this will require measuring the ratio at more than one FIO2
and using special software, so we are again at a crossroads.
Is the information from this more sophisticated approach
worth the extra effort of measurements over a range of FIO2
coupled to use of a mathematical model? The authors say
yes, and they have data to support this — a “confusion matrix”
in which gas exchange severity classified by PaO2/FIO2 ratio
changed less with FIO2 when using their two-factor model
than when using the shunt-only model. However, because the
authors have a financial interest in commercial development
of this methodology, it will be up to others to answer that
question definitively.
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